By G HossainPosted on April 13, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Telix is Regeneron’s entry ticket into the radiopharma game, helping to better round out the company’s cancer portfolio, according to Truist Securities. Regeneron enters radiopharma ring with up to $4.3B Telix alliance Post navigation Second rejection for tumor destroyer puts Replimune on a ‘challenging path’AbbVie enters world of pain in up to $715M deal with China’s Haisco